UBS maintains selective UK equity stance amid risk-off shift By Investing.com

UBS advises a selective, stock-specific approach to UK equities as FTSE New Orders have cycled through slowdown, recovery and expansion over the past six months and FY26/FY27 EPS estimates were revised slightly higher. Large-cap outperformance is led by Energy while earnings remain concentrated in Mining, Banks and Pharma; UBS flags a persistent UK discount to Europe, elevated but rotated crowding, and options pricing an active risk-off regime, recommending cash returns, balance-sheet discipline and uncrowded small/mid-cap exposures.

Analysis

The UK’s “optional market” microstructure amplifies idiosyncratic outcomes: with thin domestic sponsorship and global ownership, flows and option-driven positioning will move individual names more than indexes. That makes valuation cushion and visible cash returns (dividends/buybacks) a near-term hedge — crowded, high-PE names are the most sensitive to a quick vol repricing because options markets now make being long consensus equity positions explicitly more expensive.

Crowding has rotated into Health Care, Consumer Discretionary and Utilities while Information Technology has de-risked; this raises two second-order effects. First, liquidation in one crowded sector will cascade into other crowded sectors via cross-margin and ETF redemptions, creating 5–15% drawdowns in the most crowded large caps within weeks; second, small/mid-cap names — trading at a domestic-risk discount to book — are structurally more likely to re-rate from micro improvements because liquidity is thin and positive news travels faster through price.

Apply the microstructure and positioning backdrop to individual tickers: SMCI sits on the convex side of AI compute adoption and will outperform during any renewed capex acceleration but is vulnerable to stop-driven selling on a 20–30% pullback. APP’s momentum profile benefits from de-grossing in IT and higher implied vol, so asymmetric trades that cap downside while leaving upside intact are preferable. UBS (the bank) is a play on trading and M&A fee volatility; it will materially benefit if risk-on returns and spreads compress, but it is also exposed to near-term risk-off shocks in equity and credit markets.

Key Decisions for Investors

• SMCI — Bull call spread, 3–6 month tenor: size 1–2% NAV. Buy a near-the-money call and sell a 20–30% OTM call to fund premium. Rationale: capture convex AI capex upside while capping cost; max loss = premium paid (defined), target 2.5–4x premium if guidance/ISV wins accelerate within 3–6 months. Use a hard stop if underlying falls >25% intraday.
• APP — Long equity + protective put, 1% NAV: buy shares and purchase a 3-month 10–15% OTM put. Rationale: preserves upside from re-acceleration in ad/monetization while limiting drawdown from broad risk-off; expected breakeven requires ~10–15% price move higher in 3 months, downside limited to put cost plus tolerated delta. Trim into any >30% rally.
• UBS — Tactical long 6–12 month call spread or outright equity on a >10% pullback, size 1% NAV. Rationale: asymmetric pick for a recovery in trading/M&A activity and compression of risk premia; target +30–40% over 12 months, stop-loss -20% to protect capital if volatility and credit spreads re-widen. Avoid adding into immediate post-earnings gap reversals without confirming flow stabilization.